Kraig Biocraft Laboratories Submits Provisional Patent Applications on Multiple Spider Silk Technologies
May 22 2019 - 6:30AM
Business Wire
Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the
leading developer of spider silk based fibers, announces today that
it has submitted five new provisional patent applications, for
technologies related to its recombinant spider silk technologies.
These applications cover a broad range of technologies in the
creation, screening, and production of new recombinant proteins.
These new applications expand beyond the Company’s publicly
disclosed silkworm and silk technologies, to include advanced
construction systems, methods, and non-native proteins.
In November, of 2018, the Company retained Workman Nydegger as
its Intellectual Property counsel and expects to utilize their
expertise in prosecuting these, and all future, patent
applications.
“Our R&D team is constantly looking for opportunities to
strengthen our competitive potions, products, and processes. The
recently submitted provisional patent applications cover key
technologies and processes, invented by Dr. Kane and our team, as
well as new applications that build upon our technologies,” said
Kraig’s COO Jon Rice. “These new technologies have the potential to
significantly reduce future R&D costs and break open new
markets for recombinant protein products, reaching far beyond silks
and apparel.”
To view the most recent news from Kraig Labs and/or to sign up
for Company alerts, please go to www.KraigLabs.com/news.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a
reporting biotechnology company is the leading developer of
genetically engineered spider silk based fiber technologies.
The Company has achieved a series of scientific breakthroughs in
the area of spider silk technology with implications for the global
textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and
expectations other than historical facts are “forward-looking
statements.” These statements are made on the basis of management’s
current views and assumptions. As a result, there can be no
assurance that management’s expectations will necessarily come to
pass. These forward-looking statements generally can be identified
by phrases such as “believes,” “plans,” “expects,” “anticipates,”
“foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,”
“research,” “pilot,” “potential,” “could” or other words or phrases
of similar import. Forward looking statements include descriptions
of the Company’s business strategy, outlook, objectives, plans,
intentions and goals. All such forward-looking statements are
subject to certain risks and uncertainties that could cause actual
results to differ materially from those in forward-looking
statements. This press release does not constitute an offer to sell
or the solicitation of an offer to buy any security.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190522005255/en/
Ben Hansel, Hansel Capital, LLC(720)
288-8495ir@KraigLabs.com